Gene Symbol | MAOB |
Entrez ID | 4129 |
Uniprot ID | P27338 |
Description | monoamine oxidase B |
Chromosomal Location | chrX: 43,766,611-43,882,447 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0009636 |
response to toxic substance |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus. |
IEA |
BP |
GO:0010044 |
response to aluminum ion |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aluminum ion stimulus. |
IEA |
BP |
GO:0010269 |
response to selenium ion |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from selenium ion. |
IEA |
BP |
GO:0014063 |
negative regulation of serotonin secretion |
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of serotonin. |
IEA |
BP |
GO:0021762 |
substantia nigra development |
The progression of the substantia nigra over time from its initial formation until its mature state. The substantia nigra is the layer of gray substance that separates the posterior parts of the cerebral peduncles (tegmentum mesencephali) from the anterior parts; it normally includes a posterior compact part with many pigmented cells (pars compacta) and an anterior reticular part whose cells contain little pigment (pars reticularis). |
IEP |
BP |
GO:0032496 |
response to lipopolysaccharide |
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
IEA |
BP |
GO:0042135 |
neurotransmitter catabolic process |
The chemical reactions and pathways resulting in the breakdown of any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell. |
IEA |
BP |
GO:0042420 |
dopamine catabolic process |
The chemical reactions and pathways resulting in the breakdown of dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. |
TAS |
BP |
GO:0042493 |
response to drug |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
IEA |
BP |
GO:0045471 |
response to ethanol |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. |
IEA |
BP |
GO:0045964 |
positive regulation of dopamine metabolic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving dopamine. |
IEA |
BP |
GO:0050665 |
hydrogen peroxide biosynthetic process |
The chemical reactions and pathways resulting in the formation of hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA. |
NAS |
BP |
GO:0051412 |
response to corticosterone |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosterone stimulus. Corticosterone is a 21 carbon steroid hormone of the corticosteroid type, produced in the cortex of the adrenal glands. In many species, corticosterone is the principal glucocorticoid, involved in regulation of fuel metabolism, immune reactions, and stress responses. |
IEA |
BP |
GO:0055114 |
oxidation-reduction process |
A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons. |
IEA |
CC |
GO:0005739 |
mitochondrion |
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
IDA |
CC |
GO:0005740 |
mitochondrial envelope |
The double lipid bilayer enclosing the mitochondrion and separating its contents from the cell cytoplasm; includes the intermembrane space. |
TAS |
CC |
GO:0005741 |
mitochondrial outer membrane |
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope. |
TAS |
CC |
GO:0005743 |
mitochondrial inner membrane |
The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae. |
IEA |
CC |
GO:0016021 |
integral component of membrane |
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
IEA |
CC |
GO:0070062 |
extracellular exosome |
A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
IDA |
MF |
GO:0008131 |
primary amine oxidase activity |
Catalysis of the reaction: a primary amine + H2O + O2 = an aldehyde + NH3 + hydrogen peroxide. |
TAS |
MF |
GO:0009055 |
electron carrier activity |
Any molecular entity that serves as an electron acceptor and electron donor in an electron transport chain. An electron transport chain is a process in which a series of electron carriers operate together to transfer electrons from donors to any of several different terminal electron acceptors to generate a transmembrane electrochemical gradient. |
TAS |
MF |
GO:0042803 |
protein homodimerization activity |
Interacting selectively and non-covalently with an identical protein to form a homodimer. |
IEA |
MF |
GO:0050660 |
flavin adenine dinucleotide binding |
Interacting selectively and non-covalently with FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2. |
IEA |
Domain ID | Description |
---|---|
IPR001613 |
Flavin amine oxidase |
IPR002937 |
Amine oxidase |
IPR023753 |
FAD/NAD(P)-binding domain |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa00260 |
Glycine, serine and threonine metabolism |
KEGG |
hsa00330 |
Arginine and proline metabolism |
KEGG |
hsa00340 |
Histidine metabolism |
KEGG |
hsa00350 |
Tyrosine metabolism |
KEGG |
hsa00360 |
Phenylalanine metabolism |
KEGG |
hsa00380 |
Tryptophan metabolism |
KEGG |
hsa00982 |
Drug metabolism - cytochrome P450 |
KEGG |
hsa01100 |
Metabolic pathways |
KEGG |
hsa04726 |
Serotonergic synapse |
KEGG |
hsa04728 |
Dopaminergic synapse |
KEGG |
hsa05030 |
Cocaine addiction |
KEGG |
hsa05031 |
Amphetamine addiction |
KEGG |
hsa05034 |
Alcoholism |
KEGG |
WP465 |
Tryptophan metabolism |
WikiPathways |
WP2436 |
Dopamine metabolism |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0002395 |
Alzheimer'S Disease |
C0002888 |
Anemia, Megaloblastic |
C0004352 |
Autistic Disorder |
C0009375 |
Colonic Neoplasms |
C0014175 |
Endometriosis |
C0019151 |
Hepatic Encephalopathy |
C0020179 |
Huntington Disease |
C0020649 |
Hypotension |
C0030567 |
Parkinson Disease |
C0031511 |
Pheochromocytoma |
C0036341 |
Schizophrenia |
C2936349 |
Plaque, Amyloid |
Tissue | Cell Type |
---|---|
adrenal gland |
glandular cells |
appendix |
glandular cells |
breast |
glandular cells |
breast |
myoepithelial cells |
bronchus |
respiratory epithelial cells |
cerebral cortex |
endothelial cells |
cerebral cortex |
neuropil |
cervix, uterine |
glandular cells |
colon |
endothelial cells |
colon |
glandular cells |
duodenum |
glandular cells |
endometrium |
glandular cells |
epididymis |
glandular cells |
fallopian tube |
glandular cells |
gallbladder |
glandular cells |
heart muscle |
myocytes |
kidney |
cells in tubules |
liver |
hepatocytes |
lymph node |
germinal center cells |
nasopharynx |
respiratory epithelial cells |
oral mucosa |
squamous epithelial cells |
ovary |
ovarian stroma cells |
placenta |
decidual cells |
placenta |
trophoblastic cells |
prostate |
glandular cells |
rectum |
glandular cells |
salivary gland |
glandular cells |
skin |
fibroblasts |
small intestine |
glandular cells |
smooth muscle |
smooth muscle cells |
soft tissue |
adipocytes |
soft tissue |
peripheral nerve |
stomach |
glandular cells |
testis |
Leydig cells |
thyroid gland |
glandular cells |
urinary bladder |
urothelial cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
23824412 |
Piltonen et al. |
2013 |
Mesenchymal Stem/Progenitors and Other Endometrial Cell Types From Women With Polycystic Ovary Syndrome (PCOS) Display Inflammatory and Oncogenic Potential |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
SRPK1 |
6732 |
Q96SB4 |
0.63 |
MAOB |
4129 |
P27338 |
0.70 |
NFYB |
4801 |
P25208 |
0.63 |